PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 1652247-3 1991 RNA blot assays indicate that butyrate and dbcAMP decrease the expression of ornithine decarboxylase and c-myc genes, and stimulate the expression of the vimentin gene. Bucladesine 43-49 ornithine decarboxylase 1 Homo sapiens 77-100 11178987-1 2001 Aminoglutethimide (AMG), a potent inhibitor of steroidogenesis used in the treatment of breast cancer and some adrenal pathologies, abolished the induction of ornithine decarboxylase (ODC) elicited by peptide hormones and by dibutyryl-cAMP in steroidogenic tissues. Bucladesine 225-239 ornithine decarboxylase 1 Homo sapiens 159-182 11178987-1 2001 Aminoglutethimide (AMG), a potent inhibitor of steroidogenesis used in the treatment of breast cancer and some adrenal pathologies, abolished the induction of ornithine decarboxylase (ODC) elicited by peptide hormones and by dibutyryl-cAMP in steroidogenic tissues. Bucladesine 225-239 ornithine decarboxylase 1 Homo sapiens 184-187 2578206-6 1985 Addition of isoproterenol (10(-7)M), IBMX (1 mM) or dibutyryl cAMP (2.5 mM) to isolated aortic segments cultured in minimal salts-glucose media evoked decreases in basal levels of ODC activity resembling those observed in the intact animal. Bucladesine 52-66 ornithine decarboxylase 1 Homo sapiens 180-183 2478272-2 1989 Induction of differentiation with either retinoic acid, dimethylsulfoxide, dibutyryl cAMP or dihydroxy-vitamin D3 resulted in a decrease of the cellular content of ODC RNA. Bucladesine 75-89 ornithine decarboxylase 1 Homo sapiens 164-167 6180738-2 1982 Addition of dibutyryl cyclic AMP or 3-isobutyl-1-methylxanthine at the time of serum re-feeding further stimulated ODC activity in 3T3 fibroblasts but inhibited the serum stimulation of ODC activity in FS fibroblasts. Bucladesine 12-32 ornithine decarboxylase 1 Homo sapiens 115-118 6180738-2 1982 Addition of dibutyryl cyclic AMP or 3-isobutyl-1-methylxanthine at the time of serum re-feeding further stimulated ODC activity in 3T3 fibroblasts but inhibited the serum stimulation of ODC activity in FS fibroblasts. Bucladesine 12-32 ornithine decarboxylase 1 Homo sapiens 186-189 85547-4 1978 N,O"-Dibutyryl cAMP (1.0--10.0 mM) caused a dose-dependent stimulation of ODC activity which equaled the maximal effect of LH but was significantly less effective than the saturating dose of FSH. Bucladesine 0-19 ornithine decarboxylase 1 Homo sapiens 74-77 6249374-2 1980 Each of these amino acids induced a striking activation of ornithine decarboxylase in the presence of dibutyryl cyclic AMP and luteinizing hormone. Bucladesine 102-122 ornithine decarboxylase 1 Homo sapiens 59-82 6249374-4 1980 The active amino acids at optimal concentrations (10 mM) induced only a 10-20 fold enhancement of enzyme activity alone, while in the presence of dibutyryl cyclic AMP, ornithine decarboxylase activity was increased 40-50 fold within 7-8 h. Of the hormones and drugs tested, luteinizing hormone resulted in the highest (300-500 fold) induction of ornithine decarboxylase with optimal concentrations of dibutyryl cyclic AMP and asparagnine. Bucladesine 146-166 ornithine decarboxylase 1 Homo sapiens 168-191 6249374-4 1980 The active amino acids at optimal concentrations (10 mM) induced only a 10-20 fold enhancement of enzyme activity alone, while in the presence of dibutyryl cyclic AMP, ornithine decarboxylase activity was increased 40-50 fold within 7-8 h. Of the hormones and drugs tested, luteinizing hormone resulted in the highest (300-500 fold) induction of ornithine decarboxylase with optimal concentrations of dibutyryl cyclic AMP and asparagnine. Bucladesine 146-166 ornithine decarboxylase 1 Homo sapiens 346-369 6249374-6 1980 The induction of ornithine decarboxylase elicited by dibutyryl cyclic AMP, amino acid and luteinizing hormone was diminished about 50% with inhibitors of RNA and protein synthesis. Bucladesine 53-73 ornithine decarboxylase 1 Homo sapiens 17-40 6249374-10 1980 The induction of ornithine decarboxylase by dibutyryl cyclic AMP and luteinizing hormone was additive in the presence of an active amino acid. Bucladesine 44-64 ornithine decarboxylase 1 Homo sapiens 17-40 166887-0 1975 Involvement of hypophysis in the stimulation of liver ornithine decarboxylase by dibutyryl cyclic AMP. Bucladesine 81-101 ornithine decarboxylase 1 Homo sapiens 54-77